MiR-708 promotes steroid-induced osteonecrosis of femoral head, suppresses osteogenic differentiation by targeting SMAD3

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Hao, Cheng ^a   Yang, Shuhua ^a   Xu, Weihua ^a   Shen, Jacson K ^b   Ye, Shunan ^a   Liu, Xianzhe ^a   Dong, Zhe ^a   Xiao, Baojun ^a   Feng, Yong ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGION; GLUCOCORTICOID; MICRORNA; MIRN708 MICRORNA, HUMAN; SMAD3 PROTEIN; SMAD3 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; BONE DEVELOPMENT; CELL DIFFERENTIATION; CHEMICALLY INDUCED; DRUG EFFECTS; FEMUR HEAD NECROSIS; GENETICS; HUMAN;

3' UNTRANSLATED REGIONS; CELL DIFFERENTIATION; FEMUR HEAD NECROSIS; GLUCOCORTICOIDS; HUMANS; MICRORNAS; OSTEOGENESIS; SMAD3 PROTEIN;

EID: 84960155076     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22599     Document Type: Article

References (55)

1. Koromila, T. et al. Glucocorticoids antagonize RUNX2 during osteoblast differentiation in cultures of ST2 pluripotent mesenchymal cells. J Cell Biochem 115, 27-33, doi: 10.1002/jcb.24646 (2014).
2. Li, H. et al. miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway. Cell Death Differ doi: 10.1038/cdd.2015.99 (2015).
3. Karol, S. E. et al. Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia. Blood doi: 10.1182/blood-2015-05-643601 (2015).
4. Seo, B. M. et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 364, 149-155, doi: 10.1016/s0140-6736(04)16627-0 (2004).
5. Jing, W. et al. Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Producing IL15 Eradicate Established Pancreatic Tumor in Syngeneic Mice. Mol Cancer Ther doi: 10.1158/1535-7163.mct-14-0175 (2014).
6. Davies, O. G., Cooper, P. R., Shelton, R. M., Smith, A. J., Scheven, B. A. A comparison of the in vitro mineralisation and dentinogenic potential of mesenchymal stem cells derived from adipose tissue, bone marrow and dental pulp. J Bone Miner Metab doi: 10.1007/s00774-014-0601-y (2014).
7. Yim, R. L. et al. A Systematic Review of the Safety & Efficacy of Mesenchymal Stem Cell for Disc Degeneration: Insights & Future Directions for Regenerative Therapeutics. Stem Cells Dev doi: 10.1089/scd.2014.0203 (2014).
8. Liu, Y., Wu, J., Zhu, Y., Han, J. Therapeutic application of mesenchymal stem cells in bone and joint diseases. Clin Exp Med 14, 13-24, doi: 10.1007/s10238-012-0218-1 (2014).
9. Pittenger, M. F. et al. Multilineage potential of adult human mesenchymal stem cells. Science (New York, N.Y.) 284, 143-147 (1999).
10. Lee, J. S. et al. Alterations in the differentiation ability of mesenchymal stem cells in patients with nontraumatic osteonecrosis of the femoral head: comparative analysis according to the risk factor. J Orthop Res 24, 604-609, doi: 10.1002/jor.20078 (2006).
11. Sun, Z. et al. Aberrant CpG Islands' Hypermethylation of ABCB1 in Mesenchymal Stem Cells of Patients with Steroid-associated Osteonecrosis. J Rheumatol 40, 1913-1920, doi: 10.3899/jrheum.130191 (2013).
12. Contador, D. et al. Featured Article: Dexamethasone and rosiglitazone are sufficient and necessary for producing functional adipocytes from mesenchymal stem cells. Exp Biol Med (Maywood, N.J.) 240, 1235-1246, doi: 10.1177/1535370214566565 (2015).
13. Ke, Y., Zhao, W., Xiong, J., Cao, R. miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1. Biochem Res Int 2013, 506731, doi: 10.1155/2013/506731 (2013).
14. Krzeszinski, J. Y. et al. miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2. Nature doi: 10.1038/nature13375 (2014).
15. Lewis, B. P., Burge, C. B., Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20, doi: 10.1016/j.cell.2004.12.035 (2005).
16. Clark, E. A., Kalomoiris, S., Nolta, J. A., Fierro, F. A. Concise review: MicroRNA function in multipotent mesenchymal stromal cells. Stem cells 32, 1074-1082 (2014).
17. Shi, C. et al. Glucocorticoid inhibits cell proliferation in differentiating osteoblasts by microRNA-199a targeting of WNT signaling. J Mol Endocrinol 54, 325-337, doi: 10.1530/jme-14-0314 (2015).
18. Bian, Y. et al. Pathogenesis of glucocorticoid-induced avascular necrosis: A microarray analysis of gene expression in vitro. Int J Mol Med 36, 678-684, doi: 10.3892/ijmm.2015.2273 (2015).
19. Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317, doi: 10.1080/14653240600855905 (2006).
20. Bozic, K. J., Zurakowski, D., Thornhill, T. S. Survivorship analysis of hips treated with core decompression for nontraumatic osteonecrosis of the femoral head. J Bone Joint Surg Am 81, 200-209 (1999).
21. de Oliveira, J. C. et al. MiR-708-5p is differentially expressed in childhood acute lymphoblastic leukemia but not strongly associated to clinical features. Pediatr Blood Cancer 62, 177-178, doi: 10.1002/pbc.25222 (2015).
22. Bush, E. W., van Rooij, E. miR-25 in heart failure. Circ Res 115, 610-612, doi: 10.1161/circresaha.114.304909 (2014).
23. Zhang, L. et al. miR-92a inhibits vascular smooth muscle cell apoptosis: role of the MKK4-JNK pathway. Apoptosis 19, 975-983, doi: 10.1007/s10495-014-0987-y (2014).
24. Huntley, R. P. et al. The GOA database: gene Ontology annotation updates for 2015. Nucleic Acids Res 43, D1057-1063, doi: 10.1093/nar/gku1113 (2015).
25. Yang, X. et al. TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol 153, 35-46 (2001).
26. Selvamurugan, N., Kwok, S., Partridge, N. C. Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells. J Biol Chem 279, 27764-27773, doi: 10.1074/jbc.M312870200 (2004).
27. Ohyama, Y. et al. Runx2/Smad3 complex negatively regulates TGF-beta-induced connective tissue growth factor gene expression in vascular smooth muscle cells. J Atheroscler Thromb 19, 23-35 (2012).
28. Chen, G., Deng, C., Li, Y. P. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 8, 272-288, doi: 10.7150/ijbs.2929 (2012).
29. Kaji, H., Naito, J., Sowa, H., Sugimoto, T., Chihara, K. Smad3 differently affects osteoblast differentiation depending upon its differentiation stage. Horm Metab Res 38, 740-745, doi: 10.1055/s-2006-955085 (2006).
30. Soltanoff, C. S., Yang, S., Chen, W., Li, Y. P. Signaling networks that control the lineage commitment and differentiation of bone cells. Crit Rev Eukaryot Gene Expr 19, 1-46 (2009).
31. Fakhry, M., Hamade, E., Badran, B., Buchet, R., Magne, D. Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts. World J Stem Cells 5, 136-148, doi: 10.4252/wjsc.v5.i4.136 (2013).
32. Wang, H. et al. Dexamethasone has variable effects on mesenchymal stromal cells. Cytotherapy 14, 423-430, doi: 10.3109/14653249.2011.652735 (2012).
33. Weinstein, R. S. Glucocorticoid-induced osteoporosis and osteonecrosis. Endocrinol Metab Clin North Am 41, 595-611, doi: 10.1016/j.ecl.2012.04.004 (2012).
34. Gangaraju, V. K., Lin, H. MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol 10, 116-125, doi: 10.1038/nrm2621 (2009).
35. Meng, Y. B. et al. microRNA-21 promotes osteogenic differentiation of mesenchymal stem cells by the PI3K/beta-catenin pathway. J Orthop Res 33, 957-964, doi: 10.1002/jor.22884 (2015).
36. Su, X. et al. MiR-26a functions oppositely in osteogenic differentiation of BMSCs and ADSCs depending on distinct activation and roles of Wnt and BMP signaling pathway. Cell Death Dis 6, e1851, doi: 10.1038/cddis.2015.221 (2015).
37. Candini, O. et al. Mesenchymal progenitors aging highlights a miR-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis. Stem Cells 33, 939-950, doi: 10.1002/stem.1897 (2015).
38. Li, C. J. et al. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. J Clin Invest 125, 1509-1522, doi: 10.1172/jci77716 (2015).
39. Jeong, B. C., Kang, I. H., Hwang, Y. C., Kim, S. H., Koh, J. T. MicroRNA-194 reciprocally stimulates osteogenesis and inhibits adipogenesis via regulating COUP-TFII expression. Cell Death Dis 5, e1532, doi: 10.1038/cddis.2014.485 (2014).
40. Lin, K. T. et al. Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B. Nat Commun 6, 5917, doi: 10.1038/ncomms6917 (2015).
41. Zhang, Z. J. et al. miRNA expression profile during osteogenic differentiation of human adipose-derived stem cells. J Cell Biochem 113, 888-898 (2012).
42. Derynck, R., Zhang, Y., Feng, X. H. Smads: transcriptional activators of TGF-beta responses. Cell 95, 737-740 (1998).
43. Kang, J. S., Alliston, T., Delston, R., Derynck, R. Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. Embo j 24, 2543-2555, doi: 10.1038/sj.emboj.7600729 (2005).
44. Zheng, L., Baek, H. J., Karsenty, G., Justice, M. J. Filamin B represses chondrocyte hypertrophy in a Runx2/Smad3-dependent manner. J Cell Biol 178, 121-128, doi: 10.1083/jcb.200703113 (2007).
45. Dingwall, M., Marchildon, F., Gunanayagam, A., Louis, C. S., Wiper-Bergeron, N. Retinoic acid-induced Smad3 expression is required for the induction of osteoblastogenesis of mesenchymal stem cells. Differentiation 82, 57-65, doi: 10.1016/j.diff.2011.05.003 (2011).
46. Hjelmeland, A. B., Schilling, S. H., Guo, X., Quarles, D., Wang, X. F. Loss of Smad3-mediated negative regulation of Runx2 activity leads to an alteration in cell fate determination. Mol Cell Biol 25, 9460-9468, doi: 10.1128/mcb.25.21.9460-9468.2005 (2005).
47. Hendy, G. N., Kaji, H., Sowa, H., Lebrun, J. J., Canaff, L. Menin and TGF-beta superfamily member signaling via the Smad pathway in pituitary, parathyroid and osteoblast. Horm Metab Res 37, 375-379, doi: 10.1055/s-2005-870152 (2005).
48. Wang, F. S. et al. MicroRNA-29a protects against glucocorticoid-induced bone loss and fragility in rats by orchestrating bone acquisition and resorption. Arthritis Rheum 65, 1530-1540, doi: 10.1002/art.37948 (2013).
49. Koo, K. H. et al. Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment. Clin Rheumatol 21, 299-303, doi: 10.1007/s100670200078 (2002).
50. Gao, J. et al. MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow. J Cell Biochem 112, 1844-1856, doi: 10.1002/jcb.23106 (2011).
51. Hassan, M. Q. et al. HOXA10 controls osteoblastogenesis by directly activating bone regulatory and phenotypic genes. Mol Cell Biol 27, 3337-3352, doi: 10.1128/mcb.01544-06 (2007).
52. Hong, D. et al. Osteoblastogenic effects of dexamethasone through upregulation of TAZ expression in rat mesenchymal stem cells. J Steroid Biochem Mol Biol 116, 86-92, doi: 10.1016/j.jsbmb.2009.05.007 (2009).
53. Maragkakis, M. et al. DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Res 37, W273-276, doi: 10.1093/nar/gkp292 (2009).
54. Franchina, T. et al. Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer. J Cell Physiolm 229, 97-99, doi: 10.1002/jcp.24422 (2014).
55. Wang, L., Huang, J., Jiang, M., Sun, L. Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation. J Cell Biochem 112, 1286-1294, doi: 10.1002/jcb.23030 (2011).